Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Dexamethasone/Mifepristone/Prednisone

Exogenous Cushing's syndrome and mild nausea

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Priyadarshan S, et al. Mifepristone In Exogenous Cushing's Syndrome. Journal of the Endocrine Society 7 (Suppl.): A83, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.151 Priyadarshan S, et al. Mifepristone In Exogenous Cushing's Syndrome. Journal of the Endocrine Society 7 (Suppl.): A83, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.151
Metadaten
Titel
Dexamethasone/Mifepristone/Prednisone
Exogenous Cushing's syndrome and mild nausea
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50959-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Hydralazine

Case report

Adalimumab

Case report

Multiple drugs

Case report

Hydralazine